Because the deposition of ECM and the recruitment of immune cells as well as endothelial cells are critical steps during tumour progression7–12, we assessed the impact of ablation of stromal fibroblast-derived ZEB1 on the growth and invasion of mammary tumour epithelial cells in vivo and in vitro. This evidence concerns the gene ZEB1 and breast cancer.